Reminder: Opt in for first $1M ‘Vax to the Max’ sweepstakes drawing by 6 p.m. Thursday

SANTA FE – The state of New Mexico’s Vax 2 the Max Sweepstakes, a $10 million total cash sweepstakes funded by federal stimulus and intended to incentivize COVID-19 vaccinations, will award its first four major prizes to vaccinated New Mexicans on Friday.  

New Mexicans who have received their COVID-19 vaccination must opt in to be eligible for the sweepstakes by 6 p.m. Thursday, June 17, to be eligible for the Friday, June 18, drawing. 

As of Wednesday, June 16, more than 415,000 vaccinated New Mexicans have opted in to the sweepstakes. One $250,000 winner will be selected Friday from each of the state’s four public health regions. 

“These are going to be pretty spectacular odds for New Mexicans,” said Gov. Michelle Lujan Grisham. “New Mexicans have been through a lot this last year. I’m glad we’re going to have a little fun, and I’m grateful to New Mexicans who continue to get their shots, who encourage family and friends to get their shots, because with every vaccine administered we are one step closer to ending this pandemic.” 

Vaccinated New Mexicans may opt in at vax2themaxNM.org. 

To get your vaccine and make yourself eligible for opting in, schedule your vaccine appointment at vaccineNM.org. 

Winners will be selected by the New Mexico Lottery, which is conducting the sweepstakes on behalf of the state administration. The Department of Health will then verify the identity and vaccination status of each prospective awardee before declaring official winners.  

The rules and regulations of the sweepstakes are available here. 

New Mexicans who have received at least one COVID-19 vaccination may opt in to the sweepstakes at vax2themaxNM.org. To be eligible for the $5 million grand prize, New Mexicans must have completed their vaccination series -- so sign up for your shots soon! New Mexicans can schedule their shots at vaccineNM.org.

Media Contact

We would be happy to provide additional information about this press release. Simply contact Matt Bieber at 505-470-2290 (Office) with your questions.